His doctor told him about the injectable ahead of its release in May 2022, and he's been taking it ever since
No GLP-1 receptor agonist currently has FDA approval for treating binge eating disorder
These localized reactions typically manifest as erythema, pruritus, swelling, or discomfort at the injection site and are generally mild to moderate in severity
Both medications can cause weight loss , and their combined use may result in more pronounced weight reduction than either agent alone
Opened two months ago, The Canopy at Laskin Road is a mixed-use residential, retail and office complex featuring 132 apartments, 10,000 square feet of street-level retail and restaurant space and a more than 50,000-square-foot Class A office building that will serve as the future headquarters of the project developer, The Franklin Group